Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs YieldMax Universe Fund of Option Income ETFs — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while YieldMax Universe Fund of Option Income ETFs trades at $7.32 (market cap $366.97M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 84.3× YieldMax Universe Fund of Option Income ETFs's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while YieldMax Universe Fund of Option Income ETFs pays none. Which is the better fit depends on your goals.
| GEHC | YMAX | |
|---|---|---|
Market Cap | $30.93B | $366.97M |
Volume | 5,033,451 | 1,249,572 |
Sector | Health | Income / Options Overlay |
52-Week High | $88.16 | $12.60 |
52-Week Low | $59.48 | $7.27 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 57 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
YMAX trades at $7.61 with minimal daily movement (+0.13%). Technical indicators show a bearish trend with moving averages signaling sell pressure, though oscillators are neutral. The fund maintains a high distribution policy with weekly dividends, but faces concerns about NAV erosion and sustainability. Recent portfolio adjustments aim to address performance issues while maintaining the ~40%+ annualized yield.
The outlook remains cautious due to structural concerns about distribution sustainability and NAV erosion. While the high yield attracts income investors, the fund's reverse split potential and stacked fee structure present significant risks. Analyst sentiment is mixed, with some questioning the long-term viability of the current distribution model amid persistent principal decline.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About YieldMax Universe Fund of Option Income ETFs
YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.
Read more on YMAX →
